Literature DB >> 20334877

Effects of mood stabilizers on mitochondrial respiratory chain activity in brain of rats treated with d-amphetamine.

Samira S Valvassori1, Gislaine T Rezin, Camila L Ferreira, Morgana Moretti, Cinara L Gonçalves, Mariana R Cardoso, Emílio L Streck, Flávio Kapczinski, João Quevedo.   

Abstract

Bipolar disorder (BD) is a devastating major mental illness associated with high rates of suicide and work loss. There is an emerging body of data suggesting that bipolar disorder is associated with mitochondrial dysfunction. In this context, the present study aims to investigate the effects of mood stabilizers lithium (Li) and valproate (VPT) on mitochondrial respiratory chain activity in brain of rats undergoing treatment with the pro-manic agent d-AMPH d-amphetamine (d-AMPH). In the reversal treatment, Wistar rats were first given d-AMPH or saline for 14 days, and then, between days 8 and 14, rats were treated with Li, VPA or saline (Sal). In the prevention treatment, rats were pretreated with Li, VPA or Sal. Locomotor behavior was assessed using the open-field task and mitochondrial chain activity complexes I, II, III and IV were measured in brain structures (hippocampus, striatum and prefrontal). Li and VPA reversed and prevented d-AMPH-induced hyperactivity. In both experiments, d-AMPH inhibited mitochondrial respiratory chain activity in all analyzed structures. In the reversal treatment, VPA reversed d-AMPH-induced dysfunction in all brain regions analyzed. In the prevention experiment, the effects of Li and VPA on d-AMPH-induced mitochondrial dysfunction were dependent on the brain region analyzed. These findings suggested that dopamine can be an important link for the mitochondrial dysfunction seen in BD and, Li and VPA exert protective effects against this d-AMPH-induced mitochondrial dysfunction, but this effect varies depending on the brain region and the treatment regimen.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20334877     DOI: 10.1016/j.jpsychires.2010.02.009

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  31 in total

Review 1.  New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates--Nrf2 activators and GSK-3 inhibitors.

Authors:  Michael Maes; Zdenĕk Fišar; Miguel Medina; Giovanni Scapagnini; Gabriel Nowak; Michael Berk
Journal:  Inflammopharmacology       Date:  2012-01-24       Impact factor: 4.473

2.  Inositol-related gene knockouts mimic lithium's effect on mitochondrial function.

Authors:  Lilach Toker; Yuly Bersudsky; Inbar Plaschkes; Vered Chalifa-Caspi; Gerard T Berry; Roberto Buccafusca; Dieder Moechars; R H Belmaker; Galila Agam
Journal:  Neuropsychopharmacology       Date:  2013-08-08       Impact factor: 7.853

3.  Fenproporex increases locomotor activity and alters energy metabolism, and mood stabilizers reverse these changes: a proposal for a new animal model of mania.

Authors:  Gislaine T Rezin; Camila B Furlanetto; Giselli Scaini; Samira S Valvassori; Cinara L Gonçalves; Gabriela K Ferreira; Isabela C Jeremias; Wilson R Resende; Mariane R Cardoso; Roger B Varela; João Quevedo; Emilio L Streck
Journal:  Mol Neurobiol       Date:  2013-10-15       Impact factor: 5.590

4.  Frontal lobe bioenergetic metabolism in depressed adolescents with bipolar disorder: a phosphorus-31 magnetic resonance spectroscopy study.

Authors:  Xian-Feng Shi; Douglas G Kondo; Young-Hoon Sung; Tracy L Hellem; Kristen K Fiedler; Eun-Kee Jeong; Rebekah S Huber; Perry F Renshaw
Journal:  Bipolar Disord       Date:  2012-07-20       Impact factor: 6.744

5.  Rosiglitazone synergizes the neuroprotective effects of valproic acid against quinolinic acid-induced neurotoxicity in rats: targeting PPARγ and HDAC pathways.

Authors:  Jitendriya Mishra; Tanya Chaudhary; Anil Kumar
Journal:  Neurotox Res       Date:  2014-02-25       Impact factor: 3.911

6.  The role of reactive oxygen species in methamphetamine self-administration and dopamine release in the nucleus accumbens.

Authors:  Eun Young Jang; Chae Ha Yang; David M Hedges; Soo Phil Kim; Jun Yeon Lee; Tyler G Ekins; Brandon T Garcia; Hee Young Kim; Ashley C Nelson; Nam Jun Kim; Scott C Steffensen
Journal:  Addict Biol       Date:  2016-07-14       Impact factor: 4.280

7.  Abnormal high-energy phosphate molecule metabolism during regional brain activation in patients with bipolar disorder.

Authors:  C Yuksel; F Du; C Ravichandran; J R Goldbach; T Thida; P Lin; B Dora; J Gelda; L O'Connor; S Sehovic; S Gruber; D Ongur; B M Cohen
Journal:  Mol Psychiatry       Date:  2015-03-10       Impact factor: 15.992

8.  Effects of Mood Stabilizers on Brain Energy Metabolism in Mice Submitted to an Animal Model of Mania Induced by Paradoxical Sleep Deprivation.

Authors:  Emilio L Streck; Giselli Scaini; Gabriela C Jeremias; Gislaine T Rezin; Cinara L Gonçalves; Gabriela K Ferreira; Gislaine Z Réus; Wilson R Resende; Samira S Valvassori; Flávio Kapczinski; Mônica L Andersen; João Quevedo
Journal:  Neurochem Res       Date:  2015-04-17       Impact factor: 3.996

9.  Lithium increases leukocyte mitochondrial complex I activity in bipolar disorder during depressive episodes.

Authors:  Rafael T de Sousa; Emilio L Streck; Marcus V Zanetti; Gabriela K Ferreira; Breno S Diniz; Andre R Brunoni; Geraldo F Busatto; Wagner F Gattaz; Rodrigo Machado-Vieira
Journal:  Psychopharmacology (Berl)       Date:  2014-06-26       Impact factor: 4.530

10.  Intracerebroventricular administration of ouabain alters synaptic plasticity and dopamine release in rat medial prefrontal cortex.

Authors:  Li Sui; Xiao-Jin Song; Jie Ren; Li-Hua Ju; Yan Wang
Journal:  J Neural Transm (Vienna)       Date:  2013-01-12       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.